UY33128A - PIRIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS OF THE SAME - Google Patents
PIRIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS OF THE SAMEInfo
- Publication number
- UY33128A UY33128A UY33128A UY33128A UY33128A UY 33128 A UY33128 A UY 33128A UY 33128 A UY33128 A UY 33128A UY 33128 A UY33128 A UY 33128A UY 33128 A UY33128 A UY 33128A
- Authority
- UY
- Uruguay
- Prior art keywords
- piridinone
- derivatives
- same
- pharmaceutical compositions
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09075567 | 2009-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY33128A true UY33128A (en) | 2011-07-29 |
Family
ID=42076929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY33128A UY33128A (en) | 2009-12-22 | 2010-12-21 | PIRIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS OF THE SAME |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR079688A1 (en) |
| TW (1) | TW201130854A (en) |
| UY (1) | UY33128A (en) |
| WO (1) | WO2011076687A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012175514A1 (en) * | 2011-06-21 | 2012-12-27 | Bayer Intellectual Property Gmbh | Pyridinone derivatives and pharmaceutical compositions thereof |
| WO2014185853A1 (en) * | 2013-05-14 | 2014-11-20 | Quretech Bio Ab | Compounds and methods for treatment of chlamydia infections |
| CA2927641C (en) | 2013-10-30 | 2023-03-14 | Shanghai Hengrui Pharmaceutical Co., Ltd. | Pyrazolopyrimidone or pyrrolotriazone derivatives, method of preparing same, and pharmaceutical applications thereof |
| EP2881391A1 (en) | 2013-12-05 | 2015-06-10 | Bayer Pharma Aktiengesellschaft | Spiroindoline carbocycle derivatives and pharmaceutical compositions thereof |
| WO2016030334A2 (en) | 2014-08-26 | 2016-03-03 | Betanien Hospital | Methods, agents and compositions for treatment of inflammatory conditions |
| WO2018086608A1 (en) | 2016-11-14 | 2018-05-17 | 江苏恒瑞医药股份有限公司 | Crystalline form of gnrh receptor antagonist and preparation method therefor |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1072219C (en) | 1995-06-01 | 2001-10-03 | 武田药品工业株式会社 | Tricyclic diazepines, its production and use |
| CN1063446C (en) | 1995-10-19 | 2001-03-21 | 武田药品工业株式会社 | Thienopyridine derivatives as gonadotropin releasing hormone antagonists |
| WO1997014682A1 (en) | 1995-10-19 | 1997-04-24 | Takeda Chemical Industries, Ltd. | Quinoline derivatives as gnrh antagonists |
| US5780437A (en) | 1995-12-14 | 1998-07-14 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| NZ325569A (en) | 1995-12-14 | 2000-05-26 | Merck & Co Inc | 2-substituted phenyl-1H-indole derivatives which are antagonists of gonadotropin releasing hormone |
| US5849764A (en) | 1995-12-14 | 1998-12-15 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| CA2240115A1 (en) | 1995-12-14 | 1997-06-19 | Wallace T. Ashton | Antagonists of gonadotropin releasing hormone |
| AU709090B2 (en) | 1995-12-14 | 1999-08-19 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| CZ183198A3 (en) | 1995-12-14 | 1998-10-14 | Merck And Co., Inc. | Non-peptidic derivatives, gonadotropin-releasing antagonizing hormone and pharmaceutical preparation |
| EP0901489A1 (en) | 1996-05-20 | 1999-03-17 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| JP2000511182A (en) | 1996-05-20 | 2000-08-29 | メルク エンド カンパニー インコーポレーテッド | Gonadotropin-releasing hormone antagonists |
| CA2254768A1 (en) | 1996-05-20 | 1997-11-27 | Jinlong Jiang | Antagonists of gonadotropin releasing hormone |
| WO1997044041A1 (en) | 1996-05-20 | 1997-11-27 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| AU3043497A (en) | 1996-08-01 | 1998-02-25 | Arturne Bernard | Method for marking objects |
| WO1998055116A1 (en) | 1997-06-05 | 1998-12-10 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| JP2002502422A (en) | 1997-06-05 | 2002-01-22 | メルク エンド カンパニー インコーポレーテッド | Gonadotropin-releasing hormone antagonist |
| WO1998055470A1 (en) | 1997-06-05 | 1998-12-10 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US6313301B1 (en) | 1997-08-13 | 2001-11-06 | Takeda Chemical Industries, Ltd. | Thienopyridine derivatives, their intermediates and production thereof |
| CN1277612A (en) | 1997-12-26 | 2000-12-20 | 武田药品工业株式会社 | Nitrogen-containing heterocyclic compounds, their production and use |
| US20020065309A1 (en) | 1999-08-04 | 2002-05-30 | Ge Peng | Novel Bicyclic and tricyclic pyrrolidine derivatives as GnRH antagonists |
| EP1220857B1 (en) | 1999-10-15 | 2005-09-21 | Neurocrine Biosciences, Inc. | Gonadotropin releasing hormone receptor antagonists and their related methods of use |
| EP1233967A4 (en) | 1999-11-19 | 2003-07-09 | Univ Washington | Pyridinones to treat and prevent bacterial infections |
| DK1255738T3 (en) | 2000-01-25 | 2012-06-25 | Neurocrine Biosciences Inc | Gonadotropin-releasing hormone receptor antagonists and methods related thereto |
| US20030134863A1 (en) * | 2000-04-13 | 2003-07-17 | Shuichi Furuya | Preventives/remedies for alzheimer's disease |
| SE0100566D0 (en) | 2001-02-20 | 2001-02-20 | Astrazeneca Ab | Compounds |
| WO2003013528A1 (en) | 2001-08-02 | 2003-02-20 | Neurocrine Biosciences, Inc. | Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists. |
| WO2003011841A1 (en) | 2001-08-02 | 2003-02-13 | Neurocrine Biosciences, Inc. | 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists |
| AU2002324586B2 (en) | 2001-08-02 | 2008-04-24 | Neurocrine Biosciences, Inc. | 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| EP1412363A1 (en) | 2001-08-02 | 2004-04-28 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists |
| WO2003011293A2 (en) | 2001-08-02 | 2003-02-13 | Neurocrine Biosciences, Inc. | Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists |
| CA2531507C (en) | 2003-07-07 | 2013-10-01 | Neurocrine Biosciences, Inc. | Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| EP1987040B1 (en) | 2006-02-15 | 2010-11-10 | Actelion Pharmaceuticals Ltd. | Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives |
| AR063417A1 (en) | 2006-11-01 | 2009-01-28 | Astrazeneca Ab | INHIBITING COMPOUNDS OF TYPE 1 PLASMINOGEN ACTIVATOR (PAI-1) |
| PL2137196T3 (en) | 2007-04-20 | 2011-03-31 | Glaxo Group Ltd | Tricyclic nitrogen containing compounds as antibacterial agents |
-
2010
- 2010-12-13 TW TW099143570A patent/TW201130854A/en unknown
- 2010-12-17 WO PCT/EP2010/070092 patent/WO2011076687A1/en active Application Filing
- 2010-12-21 UY UY33128A patent/UY33128A/en not_active Application Discontinuation
- 2010-12-22 AR ARP100104867A patent/AR079688A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR079688A1 (en) | 2012-02-15 |
| TW201130854A (en) | 2011-09-16 |
| WO2011076687A1 (en) | 2011-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SMT201600350B (en) | PHARMACEUTICAL COMPOSITIONS | |
| IL224976A (en) | Substituted 1h-indazole derivatives and pharmaceutical compositions comprising them | |
| BRPI0906980A2 (en) | Composition of derivatives and maleatados | |
| BRPI1011587A2 (en) | therapeutic compounds and compositions | |
| DK3097925T3 (en) | PHARMACEUTICAL COMPOSITION | |
| IL199853A (en) | Substituted derivatives of 5-hydroxy-adamantyl-2-yl and pharmaceutical compositions comprising them | |
| BRPI1013642A2 (en) | triazine derivative and pharmaceutical composition comprising the same | |
| BRPI1004940A2 (en) | pharmaceutical composition | |
| SMT201400069B (en) | Pharmaceutical formulation | |
| IL224288A (en) | Derivatives of substituted pyrazolamide, pharmaceutical compositions comprising the same and uses thereof | |
| DK2395834T3 (en) | SODIUM NITRIT-CONTAINING PHARMACEUTICAL COMPOSITIONS | |
| BRPI1012539A2 (en) | pharmaceutical compositions | |
| BRPI0918206A2 (en) | animoester derivatives and medicinal composition of these | |
| DK3492069T3 (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING IRON-OXY-HYDROXIDE | |
| BRPI1015939A2 (en) | pharmaceutical composition | |
| SMT201400155B (en) | Pharmaceutical compositions comprising derivatives of 2-oxo-1-pyrrolidine | |
| CR10665A (en) | NEW DERIVATIVES OF DIOSMETINE, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| DK2654736T3 (en) | Unknown pharmaceutical composition | |
| BR112012010242A2 (en) | heteroarylpiperidine and heteroarylpiperazine derivatives | |
| SMT201600076B (en) | DERIVATIVES OF 2-BONE-1-PYRROLIDINYL IMIDAZOTIADIAZOL | |
| DK2391351T3 (en) | Pharmaceutical composition comprising 2-oxo-1-pyrrolidine derivatives | |
| BRPI1014688A2 (en) | therapeutic applications of quinazolinadione derivatives | |
| CO6801722A2 (en) | Pharmaceutical compositions | |
| BRPI0820198A2 (en) | pharmaceutical compositions | |
| BR112012001340A2 (en) | pharmaceutical compositions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20181127 |